Does DEGARELIX Cause Prostatic specific antigen increased? 111 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 111 reports of Prostatic specific antigen increased have been filed in association with DEGARELIX (FIRMAGON). This represents 2.9% of all adverse event reports for DEGARELIX.
111
Reports of Prostatic specific antigen increased with DEGARELIX
2.9%
of all DEGARELIX reports
9
Deaths
26
Hospitalizations
How Dangerous Is Prostatic specific antigen increased From DEGARELIX?
Of the 111 reports, 9 (8.1%) resulted in death, 26 (23.4%) required hospitalization, and 3 (2.7%) were considered life-threatening.
Is Prostatic specific antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEGARELIX. However, 111 reports have been filed with the FAERS database.
What Other Side Effects Does DEGARELIX Cause?
Injection site pain (296)
Injection site erythema (246)
Hot flush (199)
Fatigue (195)
Injection site swelling (183)
Product storage error (177)
Pyrexia (170)
Off label use (128)
Asthenia (123)
Death (120)
What Other Drugs Cause Prostatic specific antigen increased?
ENZALUTAMIDE (3,731)
LEUPROLIDE (2,432)
ABIRATERONE (1,581)
RADIUM RA-223 DICHLORIDE (449)
RELUGOLIX (335)
BICALUTAMIDE (322)
DOCETAXEL (282)
APALUTAMIDE (251)
DENOSUMAB (220)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)
Which DEGARELIX Alternatives Have Lower Prostatic specific antigen increased Risk?
DEGARELIX vs DELAFLOXACIN MEGLUMINE
DEGARELIX vs DELAMANID
DEGARELIX vs DELANDISTROGENE MOXEPARVOVEC-ROKL
DEGARELIX vs DELAVIRDINE
DEGARELIX vs DELORAZEPAM